Patients in intensive care medicine need a lung dialysis when their lungs or/and heart so severely damage and unable to serve their functions. When the usual respiratory therapy fails, such as mechanical ventilation, medicines and oxygen infusion, patients will be on extracorporeal membrane oxygenation (ECMO). It enables efficient oxygenation and elimination of carbon dioxide from blood.
There are several typed of ECMO and the two most common types are veno-arteial (VA) for cardiac or respiratory failure and veno-nenous (VV) respiratory failure. The terms VA and VV refer to the blood vessels used during the procedure. Blood is withdrawn from the patients and passes through artificial lung which provides oxygen and remove carbon dioxide.
According to markets and markets, the global respiratory care market was expected to be worth $8.8 billion in 2010 and is estimated to reach US$13.5 billion by 2015, growing at a CAGR of 8.8% from 2010-2015. The therapeutics devices market dominates the global respiratory care market, followed by monitoring devices and disposables. Within the therapeutics device market, positive airway pressure devices accounts for the largest share and is expected to be US$5.2 billion by the year 2015. The pulse oximeters market dominates the respiratory monitoring devices segment and is expected to reach a market size of US$1.7 billion by the year 2015. Within the respiratory diagnostic devices segment, spirometers dominate the market with an estimated share of US$489 million by 2015.